OvaScience to Host Second Quarter 2017 Financial Results Conference Call
July 27 2017 - 7:00AM
Business Wire
OvaScienceSM (NASDAQ: OVAS), a fertility company focused on the
discovery, development and commercialization of new treatment
options, announced today that it will host a conference call at
4:30 p.m. ET on Thursday, August 3, 2017 to discuss second quarter
2017 financial results and provide a general corporate update.
The conference call may be accessed by dialing +1-888-424-8151
for U.S. callers and +1-847-585-4422 for international callers five
minutes prior to the start of the call and providing the passcode
6428711. A live webcast of the conference call will be available
online from the Investors section of the Company’s website at
www.ovascience.com.
A replay of the conference call will be available from 7:00 p.m.
ET on Thursday, August 3, 2017, through 11:59 p.m. ET on Thursday,
August 17, 2017, and may be accessed by visiting OvaScience’s
website or by dialing +1-888-843-7419 for U.S. callers and
+1-630-652-3042 for international callers. The replay access code
is 6428711#.
About OvaScience
OvaScience, Inc. (NASDAQ: OVAS) is a global fertility company
dedicated to improving treatment options for women around the
world. OvaScience is discovering, developing and commercializing
new fertility treatments because it believes women deserve more
options. Each OvaScience treatment is based on the Company’s
proprietary technology platform that leverages the breakthrough
discovery of egg precursor (EggPCSM) cells – immature egg cells
found inside the protective ovarian lining. OvaScience is
developing OvaTureSM, a potential next-generation in vitro
fertilization (IVF) treatment that could help a woman produce
healthy, young, fertilizable eggs without hormone injections and
OvaPrimeSM, which could increase a woman’s egg reserve.
OvaScience’s AUGMENTSM treatment, a fertility option designed to
improve IVF success rates, is available in certain IVF clinics in
Canada. OvaScience treatments are not available in the U.S. For
more information, visit www.ovascience.com.
###
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170727005028/en/
Media and Investor Contact:OvaScience, Inc.Jennifer
Viera, 617-420-8748jviera@ovascience.com
Ovascience Inc. (delisted) (NASDAQ:OVAS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ovascience Inc. (delisted) (NASDAQ:OVAS)
Historical Stock Chart
From Apr 2023 to Apr 2024